InvestorsHub Logo
icon url

SkyLimit2022

12/27/23 3:28 PM

#659520 RE: exwannabe #659518

ex,

I like that opinion! 😉 I’m also looking forward to:

⭐️ Approval(s)
⭐️ Partnership(s)

I would have to disagree slightly about the combos and acceptance of the MAA being “non-news.” 😶 …The emerging combo data are brilliant, and any news on that front would be highly significant. Logically, acceptance of the MAA submission will also be significant news because acceptance precedes the review and is obviously required for approval.

Combo is King! ✅️

https://www.jci.org/articles/view/169314

https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-that-a-marketing-authorization-application-has-been-submitted-to-the-uk-mhra-for-dcvax-l-for-glioblastoma-302021038.html

https://www.uclahealth.org/news/fda-approval-brain-cancer-alzheimers

https://finance.yahoo.com/news/northwest-biotherapeutics-announces-dr-linda-140000962.html

Bullish
Bullish
icon url

flipper44

12/27/23 4:28 PM

#659543 RE: exwannabe #659518

I’m pleased that you like that you won’t be posting by August 27 or sooner. I said nothing about date of approval, although I do think my estimation of your posting end date will probably be updated soon. Stay tuned.
icon url

learningcurve2020

12/27/23 4:33 PM

#659546 RE: exwannabe #659518

Spring 2024 was just moved to Fall 2024!!!